Imperial Capital Starts AdCare Health Systems (ADK) at Outperform
Tweet Send to a FriendGet Alerts ADK Hot Sheet
Price: $4.65 -2.11%
Rating Summary:
3 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 16 | New: 13
Rating Summary:
3 Buy, 0 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 16 | New: 13
Trade ADK Now!
Imperial Capital initiates coverage on AdCare Health Systems (NYSE: ADK) with a Outperform. PT $7.00.
The firm comments, "We estimate EBITDA growth of 63% in 2013 to $36mn, driven by incremental acquisitions, optimization of its recently acquired properties, and cost leverage on the company’s increasing scale. We estimate $0.19 in EPS in 2013 vs. a pro-forma loss in 2012E. In the near term, effective management through growth challenges (closing anticipated acquisitions and a property sale, helping investors understand its revenue and EBITDA outlook, potential change of Variable Interest Entity (VIE) structure[s]) could add visibility that could contribute to EBITDA multiple expansion. Our $7 price target is based on 9.0x our 2013E EBITDA."
For an analyst ratings summary and ratings history on AdCare Health Systems click here. For more ratings news on AdCare Health Systems click here.
Shares of AdCare Health Systems closed at $4.37 yesterday, with a 52 week range of $3.15-$5.50.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
The firm comments, "We estimate EBITDA growth of 63% in 2013 to $36mn, driven by incremental acquisitions, optimization of its recently acquired properties, and cost leverage on the company’s increasing scale. We estimate $0.19 in EPS in 2013 vs. a pro-forma loss in 2012E. In the near term, effective management through growth challenges (closing anticipated acquisitions and a property sale, helping investors understand its revenue and EBITDA outlook, potential change of Variable Interest Entity (VIE) structure[s]) could add visibility that could contribute to EBITDA multiple expansion. Our $7 price target is based on 9.0x our 2013E EBITDA."
For an analyst ratings summary and ratings history on AdCare Health Systems click here. For more ratings news on AdCare Health Systems click here.
Shares of AdCare Health Systems closed at $4.37 yesterday, with a 52 week range of $3.15-$5.50.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- AdCare Health Systems Announces Notice of Noncompliance with NYSE MKT Listing Standards
- Janney Capital Boosts PT on Gap (GPS) Post Q1
- Needham & Company Lifts Numbers on Marvell (MRVL) on Solid Results
Create E-mail Alert Related Categories
New Coverage
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
